Additionally, beyond the PAR family, this study did not assess whether OC affects other GPCRs that contribute to CRC pathophysiology, such as chemokine receptors (CXCR4, CXCR1/2) or prostaglandin receptors (EP1–EP4). The gene discussed is PTGER4; the disease is colorectal carcinoma.